1 Product identity
Ingredient risk
No flagged ingredients
Chewable Digest Orange Flavor
BrandEnzymedica→Other Combinations Tablet or Pill 26 ingredients DSLD #328911Net contents: 30 Chewable Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2025-05-21
2 Ingredients (26)
IngredientGroupSafety
Total CarbohydratesCarbohydrate—
Sugar AlcoholSugar Alcohol—
AmylaseAmylase—
ProteaseProteolytic Enzymes (Proteases)—
MaltaseMaltase—
GlucoamylaseGlucoamylase—
PectinasePectinase—
LipaseLipase—
CellulaseCellulase—
PhytasePhytase—
Alpha-GalactosidaseAlpha-Galactosidase—
InvertaseSucrase—
XylanaseXylanase—
HemicellulaseHemicellulase—
Tapioca DextroseGlucose—
Citric AcidCitric Acid—
Orange Flavor, NaturalOrange (unspecified)—
AnnattoAnnatto—
Rice ConcentrateRice—
Tapioca MaltodextrinMaltodextrin—
Sunflower Lecithinlecithin—
Palm OilPalm Oil—
Guar GumGuar—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
3 Safety cross-reference
L-Leucine — Limited Evidence
⚠ May worsen pellagra
⚠ High doses may impair glucose metabolism
Lactase — Generally Safe
⚠ Very well tolerated
⚠ Fungal-derived: rare allergy
Beta-Glucan — Limited Evidence
⚠ Immune stimulation
⚠ GI effects
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID328911
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2025-05-21
6 More from Enzymedica
View Enzymedica Safety Scorecard → 27 products
AlleraseApple Cider VinegarApple Cider Vinegar GummiesBean AssistBeanAssistCarbGest7 Cite this page
Vancouver
Pkhakadze G. Chewable Digest Orange Flavor — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 27]. Available from: https://supplement.ge/products/chewable-digest-orange-flavor-328911/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG